Peer Review History
Original SubmissionJanuary 29, 2020 |
---|
PONE-D-20-02730 What do blind people “see” with retinal prostheses? Observations and qualitative reports of epiretinal implant users PLOS ONE Dear Dr. Erickson-Davis, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. I want to profoundly apologise for the delay in obtaining reviews for you. That it was harder to obtain reviewers for your paper is a reflection of current circumstances, rather than the interest in your paper. As I hope you agree, their suggestions are thoughtful and should improve the value of your paper to the field. Both reviewers noted the need for more details about the participants, how they were interviewed, and how representative of the cohort their answers might be. I do not believe this requires detailed quantitative analysis; rather further explanation in the text should be sufficient to address the reviewers' concerns. Please submit your revised manuscript by Aug 08 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Nicholas Seow Chiang Price, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please amend your current ethics statement to address the following concerns: Please explain why was written consent was not obtained, how you recorded/documented participant consent, and if the ethics committees/IRBs approved this consent procedure. 3. Please include a copy of the interview guide used in the study, in both the original language and English, as Supporting Information, or include a citation if it has been published previously. 4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 1. It is difficult to get a sense of how technically sound the manuscript is, and how well the data support the conclusions drawn, because there is some vagueness surrounding transparency of the data, and how the data were analysed. It is not possible, for instance, to know whether specific sentiments reported in the manuscript were drawn from a single interview, or aggregated from multiple sources. Consider ways in which the manuscript might be able to indicate how gathered sentiments regarding various aspects of artificial vision are shared across the population included in the study. 2. No statistical analysis was performed. Not applicable. 3. No. While the authors appear to claim that they have made all data publicly available, patient data remains confidential. If possible, the authors should de-identify data and make it publicly available. This would also support question 1. 4. Yes. The manuscript is excellently written and easily intelligible. Reviewer #2: This is an important and needed paper. I worked with retinal prosthesis persons and the patients’ reports were often disheartening given their disappointment and the consequent implant disuse. I commend the authors for finally writing a qualitative report of what these patients feel and how/whether they find the new information useful at all. However, the manuscript could be improved in many respects and thus I have suggested a number of minor and major revisions below: Line 85: “Meanwhile, there many other” I believe should be ‘there are’ Line 90: “impacted by RP” please define RP the first time you use it Throughout the manuscript do not use abbreviations, e.g. isn’t should be replaced by is not, don’t by do not etc… Line 126-127: “as well as to our understanding of vision more generally.” How does adding subjective experience help with our understanding of vision more generally? This statement needs a bit more elaboration as the vision afforded by these prostheses is quite different from typical vision so what knowledge do this study add to our understanding of vision more generally? This is unclear in the introduction but also in the discussion Line 158 to 167: “I believe this type of information about the authors is unnecessary here but can be moved to the supplemental material Line 212-214: “Nine of these participants will be presented in this article, we anonymously called them: Douglas, Vincent, Isabelle, Arthur, Eve, Thomas, Danny, Benoit, and Mathew.” Not sure I follow this, if participants were 16 why 9 of these participants are presented? Or are these additional to the 16? Please clarify, also why using names at all you could just use participant 1, 2, 3 etc…as better way of maintaining participants anonymous The information about the Interview is quite vague and would not allow replication. Please add all the interview used in the supplemental material and refer to it in the main manuscript, also report few example questions also in the main manuscript to explain what type of interview was/what type of questions were used. The same applies to the Data analysis, please give more information, e.g. “These data were supplemented with observational data collected by the authors, translated into field notes that were then subject to qualitative coding methods [46].” Line 235-236, how were the data supplemented by observational data exactly and what qualitative coding methods? The method and analysis should be clear and detailed enough to allow for replication It would be good to add a figure with a photo of the two implant systems examined in the present paper somewhere relevant in the manuscript Line 250-251: “To be eligible to receive one of these devices the individual 250 must have bare light perception or no light perception (in order to warrant the risk of the device further damaging any residual vision).” Is this the only eligibility criterion? Line 260: “techniques)” full stop is missing Line 274: “in particular the psychological profile individual subjects” I believe should be of individual subjects Line 295-296: “which receives power wirelessly coil and electronics case either a 60 or 150-electrode array that is fixed to the inner surface of the retina.” This sentence is quite difficult to follow and understand please rephrase it Although I agree that a qualitative study on the subjective experience of the implants was long overdue, using one method as the authors mention themselves is always limited as the link between subjective and more objective measures remains unclear, so why not using a mixed-method approach? With both qualitative and quantitative measures obtained and examined together? A discussion of this limitation and suggestion for future direction should be added in the Discussion (the authors mention this limitation but no clear suggestions for future research are given) Fig. 2 would be good to have an actual photo of the carved stimuli used rather than a sketch Line 384 to 386: “Douglas must answer which of the 10 they are applying electrical stimulation and which ones they aren’t. Yes or no, they ask him, do you see anything? He gets 10 out of 10 correct, each with resounding “no” and “yes.” The task is unclear here, were participants asked to answer after each stimulation if a stimulation occurred or not? Please clarify Line 442: “one’s visual experience the way it is for anyone to describe” difficult to understand needs rephrasing Line 454: “When individuals are ready to commence with camera activation” how is this decided and how it varies? Line 460-462: “(i.e. depending on the device there are between 3 to 4 different image processing modes e.g. white-on-black, inverse (black-on-white), edge detection, and motion detection).” Can a figure representing all these different modes be added? Line 482: “resulting in the participants must make constant scanning” resulting in participants having to make Line 488: “they zone in on an object” I believe you mean zoom in Line 493: “in this way it requires that they rethink the concept of “seeing.”” It requires them rethinking the concept of “seeing”. Line 525: “He says while he passes the again.” He passes the sheet in front Isabelle again. It is very useful to have a clear description of all the phases involved in the process required to deliver and use a retinal implant, however the data and subjective reports are scarce given the 16 participants tested, it would be good to have more examples of participants reports throughout the manuscript and a table with examples on a specific theme from all participants to better understand the subjective variability and experience with the implants, also it would be useful to report, the age of the participant what implant the participant was using as two are examined here when reporting quotations [e.g. quote, Participant 1, female, 56 years, ARGUS II] at the moment the manuscript reads more as a description of the retina implant process than of the subjective experience of the participants which was the main aim of the study. Line 614-615: please use participants rather than ‘them’ twice in a sentence, e.g “The vision therapist walks along beside them, tracking the translation of the video camera image into electrode activation on a laptop they tow alongside them on a wheeled walker.” The vision therapist walks along beside the participant, ….them on a wheeled walker. Line 694: “This accords with published literature” better “this is in agreement or in line with”, also some more references are needed in these sentence, what published literature? Is just one study? [23]? Explain how is in agreement with this study, what did they show? Line 794: “lest it endanger” because it could endanger Line 823-827: “While “visual” in terms of being similar to what participants remember of the experience of certain kinds of light, as well as by offering the possibility of being able to understand features of the environmental surround at a distance, artificial vision was described as both qualitatively and functionally different than the “natural” vision the participants remember.” Very long and difficult to follow sentence consider splitting it into two sentences and rephrase it Line 829: “and more a substitution; that is, as offering an entirely different or novel sensory tool” I agree but then there are lots of sensory substitution devices (e.g. The vOICe) that are less invasive and less difficult to use and are free, so why going through all this process? A discussion of this point would be important as these implants are as you mention cognitively heavy and at least similar (if not at times better) goals can be achieved with sensory substitution devices relying on available and intact senses such as sound and touch rather than lost vision Line 869: “The more early” the earlier Line 876: “we found that that the participant’s” delete one “that” In the discussion it would be good to underline how the use of these implants is discontinued by the far majority of patients and whether anything emerged in the interviews and data that could be done to improve this outcome ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
Revision 1 |
PONE-D-20-02730R1 What do blind people “see” with retinal prostheses? Observations and qualitative reports of epiretinal implant users PLOS ONE Dear Dr. Erickson-Davis, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Only minor changes are required, which I wanted you to have the opportunity to address quickly. The manuscript will not have to go back to review, provided you only make the changes suggested by the reviewers. Please submit your revised manuscript by Jan 10 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Nicholas Seow Chiang Price, Ph.D. Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Excellent, substantive revisions. This is an important piece of work, and I'm excited to see more qualitative discussion of the experience of prosthetic vision in the field. I'm happy with the paper as-is, but the authors could continue to check the added text for typos/grammatical errors. Reviewer #2: I have very few minor comments There seems to be a comment in the supplemental material that the authors may want to delete In the abstract ‘scores of them closely” is unclear, scores of what? From page 16. P1 P2 etc…shouldn’t they be R1, R2 ect…given the use of Recipient 1, 2 etc…? ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 2 |
What do blind people “see” with retinal prostheses? Observations and qualitative reports of epiretinal implant users PONE-D-20-02730R2 Dear Dr. Erickson-Davis, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Nicholas Seow Chiang Price, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
Formally Accepted |
PONE-D-20-02730R2 What do blind people “see” with retinal prostheses? Observations and qualitative reports of epiretinal implant users Dear Dr. Erickson-Davis: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Nicholas Seow Chiang Price Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .